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Aspiration thrombectomy with the AngioVac is approved for percutaneous
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removal of thrombus in the venous system. While not approved for aspiration of
thrombus or other mass in the left heart or arterial system, it has been used in
that setting. Patients with left heart or arterial mass are often deemed
unfavorable for surgery and treated conservatively. This may not be the best
option for all patients, as some may have lesions that represent a short‐term
increased risk of complications, for which intervention and aspiration could be
considered reasonable. Unfortunately, femoral arteries sizes often cannot
accommodate the Angiovac current aspiration cannula dimensions. Here, we
demonstrated trans‐caval approach for aspiration thrombectomy of extensive
aortic mobile plaque and thrombus.
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| INTRODUCTION

2 |

CASE REPORT

Plaque and thrombus are not uncommonly found in the

A 67‐year‐old female suffered a recent left middle‐cerebral‐artery (MCA)

aorta and occasionally they become symptomatic, causing

infarct treated with thrombolytic therapy, resulting in good neurological

catastrophic consequence such as embolic stroke or acute

recovery. Trans‐esophageal echocardiography (TEE) showed normal left

limb ischemia. Currently, there is no approved nonsurgical

ventricular ejection fraction with no intracardiac thrombus and no patent

treatment for these conditions. However, off‐label use of

foramen ovale. No atrial fibrillation or significant carotid artery disease

devices such as AngioVac (Vortex Med. Inc.) has been

was detected. Computer tomography (CT) aortogram revealed multiple

reported. Unfortunately, femoral arteries sizes often cannot

mobile large atherosclerotic plaques with superimposed thrombi protrud-

accommodate the Angiovac current aspiration cannula dimen-

ing into the aorta at multiple locations. After 5 months of anticoagulation,

sions.

Here,

we

demonstrated

trans‐caval

approach

for

there was only modest decrease in size of lesions (Figure 1A; Supporting

aspiration thrombectomy of extensive aortic mobile plaque and

Information: Video 1A). Multidisciplinary discussion concluded that off‐

thrombus.

label use of AngioVac was reasonable.

Abbreviations: MCA, middle cerebral artery; MRI, magnetic resonance imaging; TEE, transesophageal echocardiogram.
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Detailed analysis of the CT aortogram showed bilateral femoral

Aspiration thrombectomy and atherectomy with Angiovac were

arteries of insufficient size to accommodate the 25Fr aspiration

performed to the three target sites in the descending aorta and aortic

cannula (Figure 2A). CT revealed trans‐caval access was likely feasible

arch. Multiple maneuvers were used to facilitate aspiration of lesions:

(Figure 2B).
To mitigate risk of embolic stroke during aspiration,
Sentinel cerebral protection device (Boston Scientific) was

(1) Through AngioVac suction cannula: Plaque manipulation with
Lunderquist

wire

and

7Fr

pigtail

catheter

sequentially

placed via the right radial artery. The left vertebral artery

(Figure 4A–D; Supporting Information: Video 2; Figure 5A–F;

circulation was protected by inflating a 8 mm Armada balloon

Supporting Information: Video 3).

(Abbott Vascular) in the ostial left subclavian artery during
aspiration (Figure 3A).
Cavo‐aortic puncture was performed with Astato XS20,
inside a CXI 0.035 and 0.018 system, via a RDC catheter.

(2) Through contralateral/left femoral artery access: Plaque manipulation with J‐wire, 7Fr pigtail catheter and ensnaring via JR4/
JL3.5 guiding catheter. Balloon apposition at the aortic arch with
a 22 mm TyShak Balloon (Figure 4E,F).

After sending of Lunderquist wire through the cavo‐aortic tract,
a 26Fr Gore DrySeal sheath (Gore Medical) was delivered
(Figure 3B).

Significant

volume

of

atheroma

and

thrombus

were

aspirated. Pathological analysis of specimens confirmed calcified

F I G U R E 1 Computer tomography aortogram before and after AngioVac. (A) Before AngioVac. (B) After AngioVac. [Color figure can be
viewed at wileyonlinelibrary.com]

FIGURE 2

Computer tomography planning. (A) Bilateral femoral arteries sizing. (B) Transcaval access window planning.
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F I G U R E 3 Intraoperative setup for AngioVac. (A) Complete cerebral protection with Sentinel device and 8 mm Armada balloon.
(B) Transcaval and inferior vena cava sheath placement. [Color figure can be viewed at wileyonlinelibrary.com]

F I G U R E 4 AngioVac with assisting maneuvers. (A) AngioVac of descending aorta mass. (B) AngioVac of aortic arch mass. (C) Lunderquist
wire manipulation. (D) Pigtail manipulation. (E) EnSnare manipulation. (F) TyShak balloon manipulation.

atherosclerotic plaque and thrombus (Figure 6A,B). The iatro-

ADO1 with the aorta (Figure 7B). Aortogram demonstrated Type

genic caval access hole was closed with an Amplatzer 12/10 mm

0 closure: no fistulous or retroperitoneal flow (Figure 7C).

ADO1 (Abbott Vascular) (Figure 7A). A 14‐mm Armada balloon

Postoperatively the patient was neurologically intact and was

from left femoral artery was used to improve apposition of the

discharged on post‐op Day 1, with coumadin. 3‐month CT revealed

1522726x, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ccd.30491 by Henry Ford Health System, Wiley Online Library on [14/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

CHIANG

|

CHIANG

ET AL.

F I G U R E 5 Intraoperative Transesophageal echocardiography (TEE) images. (A) Mobile aorta masses. (B) The largest mass was identified.
(C) AngioVac targeting mass with 3D TEE guidance. (D) AngioVac targeting mass with 2D TEE guidance. (E) Largest mass before AngioVac.
(F) Minimal residual mass after AngioVac. [Color figure can be viewed at wileyonlinelibrary.com]

little‐to‐no residual aortic plaque/thrombi burden (Figure 1B; Supporting Information: Video 1B).

Transcaval access carries risk of bleeding, stroke, bowel or intra‐
abdominal organ injury, etc. However, with detailed CT planning,
complication risk can be minimized. It has been well demonstrated in
publication,1 that Transcaval access is a safe alternative for large bore

3

| DISC US SION

arterial access. Due to its safety, Transcaval access is gaining global
interest to extend its use to non‐TAVR procedures like AngioVac or

Large mobile plaque or thrombus inside the aorta are not

mechanical circulatory support.2

uncommonly encountered. While most of them are asymptomatic

To our knowledge, this is the first trans‐caval approach of

requiring only risk factor control, a minority of them are

aspiration atherectomy/thrombectomy of aorta with AngioVac.

symptomatic with catastrophic embolic consequences, like major

AngioVac is labeled for aspiration of masses/clot on the right side

stroke, in our case. However, for these symptomatic cases, there

of the heart. However, there are numerous patients with left heart or

are limited treatment options. Complete aortic replacement is a

aortic masses/clot, who are unfavorable surgical candidates. Suc-

feasible option but carries major operative risk. Extensive

cessful cases of left heart3 and aortic4 AngioVac have been reported.

endovascular stent graft is also another option, but may

As femoral artery sizes often cannot accommodate the large size

jeopardize major aortic branches, including the renal arteries or

aspiration cannula, we demonstrate that trans‐caval approach

aortic arch branches. Hence, AngioVac was chosen as a relatively

enables safe and effective aspiration thrombectomy with Angiovac

safer option.

in the arterial system.
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F I G U R E 6 Plaques and thrombus aspirated. (A) Masses aspirated. (B) Multiple plaques and thrombus aspirated. [Color figure can be viewed
at wileyonlinelibrary.com]

F I G U R E 7 Transcaval hole closure. (A) Closure with 12/10 Amplatzer ADO1. (B) Apposition with 14 mm Armada balloon. (C) Aortogram
demonstrating Type 0 closure. [Color figure can be viewed at [Color figure can be viewed at wileyonlinelibrary.com]
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Scientific, and Medtronic. Dr. W O'Neill has served as a consultant
for Abiomed, Edwards Lifesciences, Medtronic, Boston Scientific,

We demonstrated that off‐label use of AngioVac is feasible, safe, and

Abbott Vascular, and St. Jude Medical; and serves on the Board of

effective for treatment of unstable symptomatic aortic thrombus/

Directors of Neovasc Inc. All other authors report no relevant

plaque. Trans‐caval approach is a feasible and safe option even for

financial disclosures.

very large trans‐caval access size (26Fr), for patients with inadequate
femoral artery sizes.
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SUPP ORTING INFO RM ATION
Additional supporting information can be found online in the
Supporting Information section at the end of this article.
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